Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients

NCT04022616 is registered in ClinicalTrials.gov with Ohio State University Comprehensive Cancer Center as lead sponsor.

NCT NCT04022616
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04022616 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients
Lead sponsor
Ohio State University Comprehensive Cancer Center
Phase
Observational
Overall status
Recruiting
Start date
June 4, 2010
Completion date
December 31, 2027
Enrollment
99 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer